This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hiroshi Yukiura: Innovator in Antibody-Drug Conjugates
Introduction
Hiroshi Yukiura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions.
Latest Patents
Hiroshi Yukiura holds a patent for an "ANTI-EGFR ANTIBODY-DRUG CONJUGATE WITH A CYCLIC DINUCLEOTIDE DERIVATIVE." This invention represents a notable advancement in targeted cancer therapies, showcasing his expertise in the intersection of immunology and drug development. He has 1 patent to his name.
Career Highlights
Yukiura is currently employed at Daiichi Sankyo Company, Limited, a leading global pharmaceutical company. His work at Daiichi Sankyo focuses on developing innovative treatments that address critical health challenges.
Collaborations
Throughout his career, Hiroshi has collaborated with esteemed colleagues, including Masayuki Ishizaki and Osamu Suzuki. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking therapies.
Conclusion
Hiroshi Yukiura's contributions to the field of biotechnology and his innovative patent highlight his role as a key figure in advancing cancer treatment. His work continues to inspire future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile